Start
•
Completion

Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray

RecruitingRegisteredCTG

This randomized, controlled pragmatic trial (n=70) assesses the value of adding edupression.com® as a therapy adjunct to esketamine nasal spray in therapy-resistant depressive (TRD) patients.

Details

Pragmatic randomised parallel-group trial (n=70) comparing treatment-as-usual with esketamine nasal spray plus access to edupression.com® versus esketamine alone in patients with therapy-resistant depression.

Edupression.com® is a licensed, CBT-based digital self-help program (psychoeducation, CBT elements and mood tracking). The study evaluates whether adding this low-intensity psychosocial intervention to esketamine treatment improves clinical outcomes in TRD.

Topics:Treatment-Resistant Depression (TRD)

Registry

Registry linkNCT04843462